Status:
COMPLETED
Study of Predictors of Failure of Sulprostone Treatment in Postpartum Hemorrhage
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18+ years
Brief Summary
The investigators wish to identify potential factors predicting failure of second-line drug treatment (sulproston (Nalador®)): risk factors and factors linked to a failure to take initial care for PPH...
Eligibility Criteria
Inclusion
- Major subject (≥18 years old)
- Subject having given birth at HUS or CHU Poissy Saint-Germain-en Laye between 01/01/2019 and 31/12/2020
- Subject having presented a postpartum haemorrhage treated with Sulprostone
- Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research
Exclusion
- Subject having expressed opposition to participating in the study
- Subject under guardianship or guardianship
- Subject under safeguard of justice
Key Trial Info
Start Date :
October 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06164236
Start Date
October 19 2020
End Date
April 19 2024
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
École de sages-femmes de Strasbourg
Strasbourg, Starsbourg, France, 67091